Literature DB >> 23023371

Myeloid-specific IκB kinase β deficiency decreases atherosclerosis in low-density lipoprotein receptor-deficient mice.

Se-Hyung Park1, Yipeng Sui, Florence Gizard, Jinxian Xu, Jennifer Rios-Pilier, Robert N Helsley, Seong-Su Han, Changcheng Zhou.   

Abstract

OBJECTIVE: Inflammatory responses are the driving force of atherosclerosis development. IκB kinase β (IKKβ), a central coordinator in inflammation through regulation of nuclear factor-κB, has been implicated in the pathogenesis of atherosclerosis. Macrophages play an essential role in the initiation and progression of atherosclerosis, yet the role of macrophage IKKβ in atherosclerosis remains elusive and controversial. This study aims to investigate the impact of IKKβ expression on macrophage functions and to assess the effect of myeloid-specific IKKβ deletion on atherosclerosis development. METHODS AND
RESULTS: To explore the issue of macrophage IKKβ involvement of atherogenesis, we generated myeloid-specific IKKβ-deficient low-density lipoprotein receptor-deficient mice (IKKβ(ΔMye)LDLR(-/-)). Deficiency of IKKβ in myeloid cells did not affect plasma lipid levels but significantly decreased diet-induced atherosclerotic lesion areas in the aortic root, brachiocephalic artery, and aortic arch of low-density lipoprotein receptor-deficient mice. Ablation of myeloid IKKβ attenuated macrophage inflammatory responses and decreased atherosclerotic lesional inflammation. Furthermore, deficiency of IKKβ decreased adhesion, migration, and lipid uptake in macrophages.
CONCLUSIONS: The present study demonstrates a pivotal role for myeloid IKKβ expression in atherosclerosis by modulating macrophage functions involved in atherogenesis. These results suggest that inhibiting nuclear factor-κB activation in macrophages may represent a feasible approach to combat atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23023371      PMCID: PMC3979309          DOI: 10.1161/ATVBAHA.112.254573

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  40 in total

1.  Purified hematopoietic stem cells can differentiate into hepatocytes in vivo.

Authors:  E Lagasse; H Connors; M Al-Dhalimy; M Reitsma; M Dohse; L Osborne; X Wang; M Finegold; I L Weissman; M Grompe
Journal:  Nat Med       Date:  2000-11       Impact factor: 53.440

2.  Hepatocytes from non-hepatic adult stem cells.

Authors:  M R Alison; R Poulsom; R Jeffery; A P Dhillon; A Quaglia; J Jacob; M Novelli; G Prentice; J Williamson; N A Wright
Journal:  Nature       Date:  2000-07-20       Impact factor: 49.962

3.  Conditional gene targeting in macrophages and granulocytes using LysMcre mice.

Authors:  B E Clausen; C Burkhardt; W Reith; R Renkawitz; I Förster
Journal:  Transgenic Res       Date:  1999-08       Impact factor: 2.788

Review 4.  NF-κB, inflammation, and metabolic disease.

Authors:  Rebecca G Baker; Matthew S Hayden; Sankar Ghosh
Journal:  Cell Metab       Date:  2011-01-05       Impact factor: 27.287

5.  Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A.

Authors:  V R Babaev; L A Gleaves; K J Carter; H Suzuki; T Kodama; S Fazio; M F Linton
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-12       Impact factor: 8.311

6.  Polychlorinated biphenyl-induced VCAM-1 expression is attenuated in aortic endothelial cells isolated from caveolin-1 deficient mice.

Authors:  Sung Gu Han; Sung Yong Eum; Michal Toborek; Eric Smart; Bernhard Hennig
Journal:  Toxicol Appl Pharmacol       Date:  2010-04-18       Impact factor: 4.219

Review 7.  Atherosclerosis.

Authors:  A J Lusis
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

8.  Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis.

Authors:  Ralph Gareus; Elena Kotsaki; Sofia Xanthoulea; Ingeborg van der Made; Marion J J Gijbels; Rozina Kardakaris; Apostolos Polykratis; George Kollias; Menno P J de Winther; Manolis Pasparakis
Journal:  Cell Metab       Date:  2008-11       Impact factor: 27.287

9.  The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-kappaB target genes.

Authors:  Susanne Wolfrum; Daniel Teupser; Marietta Tan; Kwan Y Chen; Jan L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-15       Impact factor: 11.205

10.  Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice.

Authors:  Jennifer J Manning-Tobin; Kathryn J Moore; Tracie A Seimon; Susan A Bell; Maia Sharuk; Jacqueline I Alvarez-Leite; Menno P J de Winther; Ira Tabas; Mason W Freeman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-10-23       Impact factor: 8.311

View more
  35 in total

1.  NF-κB inhibitor targeted to activated endothelium demonstrates a critical role of endothelial NF-κB in immune-mediated diseases.

Authors:  Bettina Sehnert; Harald Burkhardt; Johannes T Wessels; Agnes Schröder; Michael J May; Dietmar Vestweber; Jochen Zwerina; Klaus Warnatz; Falk Nimmerjahn; Georg Schett; Stefan Dübel; Reinhard Edmund Voll
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-23       Impact factor: 11.205

2.  Intermittent hypoxia and hypercapnia induces inhibitor of nuclear factor-κB kinase subunit β-dependent atherosclerosis in pulmonary arteries.

Authors:  Toshihiro Imamura; Jin Xue; Orit Poulsen; Dan Zhou; Michael Karin; Gabriel G Haddad
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-10-16       Impact factor: 3.619

Review 3.  The CD44-HA axis and inflammation in atherosclerosis: A temporal perspective.

Authors:  Mia Krolikoski; James Monslow; Ellen Puré
Journal:  Matrix Biol       Date:  2018-05-21       Impact factor: 11.583

4.  Liver-specific transgenic expression of cholesteryl ester hydrolase reduces atherosclerosis in Ldlr-/- mice.

Authors:  Jinghua Bie; Jing Wang; Quan Yuan; Genta Kakiyama; Siddhartha S Ghosh; Shobha Ghosh
Journal:  J Lipid Res       Date:  2014-02-21       Impact factor: 5.922

Review 5.  Novel functions of PXR in cardiometabolic disease.

Authors:  Changcheng Zhou
Journal:  Biochim Biophys Acta       Date:  2016-02-26

6.  Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.

Authors:  Yusuke Higashi; Sergiy Sukhanov; Shaw-Yung Shai; Svitlana Danchuk; Richard Tang; Patricia Snarski; Zhaohui Li; Patricia Lobelle-Rich; Meifang Wang; Derek Wang; Hong Yu; Ronald Korthuis; Patrice Delafontaine
Journal:  Circulation       Date:  2016-05-06       Impact factor: 29.690

Review 7.  Endothelial microRNAs and atherosclerosis.

Authors:  Xinghui Sun; Nathan Belkin; Mark W Feinberg
Journal:  Curr Atheroscler Rep       Date:  2013-12       Impact factor: 5.113

8.  Liver-specific cholesteryl ester hydrolase deficiency attenuates sterol elimination in the feces and increases atherosclerosis in ldlr-/- mice.

Authors:  Jinghua Bie; Jing Wang; Kathryn E Marqueen; Rachel Osborne; Genta Kakiyama; William Korzun; Siddhartha S Ghosh; Shobha Ghosh
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-06-06       Impact factor: 8.311

9.  Leukocyte Calpain Deficiency Reduces Angiotensin II-Induced Inflammation and Atherosclerosis But Not Abdominal Aortic Aneurysms in Mice.

Authors:  Deborah A Howatt; Anju Balakrishnan; Jessica J Moorleghen; Latha Muniappan; Debra L Rateri; Haruhito A Uchida; Jiro Takano; Takaomi C Saido; Athar H Chishti; Laurent Baud; Venkateswaran Subramanian
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-03-10       Impact factor: 8.311

10.  Targeting IκB kinase β in Adipocyte Lineage Cells for Treatment of Obesity and Metabolic Dysfunctions.

Authors:  Robert N Helsley; Yipeng Sui; Se-Hyung Park; Zun Liu; Richard G Lee; Beibei Zhu; Philip A Kern; Changcheng Zhou
Journal:  Stem Cells       Date:  2016-03-28       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.